(Q36147888)

12 August 2017

High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families (English)

1 reference

12 August 2017

Marko Hocevar

1

1 reference

12 August 2017

Magdalena Avbelj

2

1 reference

12 August 2017

Barbara Perić

3

1 reference

12 August 2017

Janez Zgajnar

4

1 reference

12 August 2017

Nikola Besić

5

1 reference

12 August 2017

Tadej Battelino

6

1 reference

12 August 2017

1 December 2006

1 reference

12 August 2017

Croatian Medical Journal

1 reference

12 August 2017

47

1 reference

12 August 2017

6

1 reference

12 August 2017

851-854

1 reference

Geographical variation in the penetrance of CDKN2A mutations for melanoma

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080476

Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080476

A simple salting out procedure for extracting DNA from human nucleated cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080476

Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effect

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080476

CDKN2A germline splicing mutation affecting both p16ink4 and p14arf RNA processing in a melanoma/neurofibroma kindred

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080476

CDKN2a/p16INK4a Mutations and Lack of p19ARF Involvement in Familial Melanoma Kindreds

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080476

High prevalence of the G101W germline mutation in theCDKN2A(P16ink4a) gene in 62 Italian malignant melanoma families

5 December 2018

1 reference

12 December 2020

A novel L94Q mutation in the CDKN2A gene in a melanoma kindred

1 reference

12 December 2020

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

1 reference

12 December 2020

Germline CDKN2A mutations in childhood melanoma

1 reference

12 December 2020

Screening for tumour suppressor p16(CDKN2A) germline mutations in Israeli melanoma families

1 reference

12 December 2020

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma

1 reference

12 December 2020

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas

1 reference

12 December 2020

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]

1 reference

12 December 2020

Identifiers

1 reference

12 August 2017

PubMed publication ID

17167857

1 reference